BioSig Technologies, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for BioSig Technologies, Inc. (BSGM) is 13.90

According to BioSig Technologies, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.90. This represents a change of 253.56% compared to the average of 3.93 of the last 4 quarters.

BioSig Technologies, Inc. (BSGM) Historical Current Ratio (quarterly & annually)

How has BSGM Current Ratio performed in the past?

The mean historical Current Ratio of BioSig Technologies, Inc. over the last ten years is 2.24. The current 13.90 Current Ratio has changed 62.01% with respect to the historical average. Over the past ten years (40 quarters), BSGM's Current Ratio was at its highest in in the March 2026 quarter at 13.90. The Current Ratio was at its lowest in in the June 2025 quarter at 0.03.

BioSig Technologies, Inc. (BSGM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioSig Technologies, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioSig Technologies, Inc. (BSGM) Average Current Ratio

How has BSGM Current Ratio performed in the past?

The current Current Ratio of BioSig Technologies, Inc. (BSGM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioSig Technologies, Inc. (BSGM) Current Ratio vs. Peers

How is BSGM’s Current Ratio compared to its peers?

BioSig Technologies, Inc.’s Current Ratio is greater than Nevro Corp. (4.62), greater than Vaccitech plc (6.05), greater than Zevra Therapeutics, Inc. (4.89), greater than LakeShore Biopharma Co., Ltd (1.02), greater than Second Sight Medical Products Inc (3.18), less than Theseus Pharmaceuticals, Inc. (17.79), greater than LENZ Therapeutics, Inc. (10.40), greater than Societal CDMO, Inc. (1.07), greater than Alaunos Therapeutics, Inc. (1.63), greater than Spectrum Pharmaceuticals, Inc. (2.37),

Build a custom stock screener for BioSig Technologies, Inc. (BSGM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioSig Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioSig Technologies, Inc. (BSGM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioSig Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.